Skip to main content
. 2021 Sep 28;13(19):4869. doi: 10.3390/cancers13194869

Figure 1.

Figure 1

Waterfall plot of tumor response depicted as percentage of tumor volume change phase I and II combined for the patients of phase I that received prior treatment with FOLFIRINOX and treatment with LDE225 200 mg.